The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 17, 2023

Filed:

Dec. 07, 2017
Applicant:

Vilnius Univeristy, Vilnius, LT;

Inventors:

Virginijus {hacek over (S)}ik{hacek over (s)}nys, Vilnius, LT;

Giedrius Gasiunas, Bir{hacek over (z)}u r., LT;

Tautvydas Karvelis, Vilniaus r., LT;

Arvydas Lubys, Vilnius, LT;

Lolita Zaliauskiene, Vilnius, LT;

Monika Gasiuniene, Vilnius, LT;

Anja Smith, Lafayette, CO (US);

Assignee:

Vilnius University, Vilnius, LT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 15/10 (2006.01); C12Q 1/6811 (2018.01); C12P 19/34 (2006.01); C12N 9/22 (2006.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12N 9/22 (2013.01); C12N 15/102 (2013.01); C12N 15/902 (2013.01); C12N 15/907 (2013.01); C12P 19/34 (2013.01); C12Q 1/6811 (2013.01); C12N 2310/12 (2013.01); C12N 2310/14 (2013.01); C12N 2310/20 (2017.05); C12N 2310/3513 (2013.01); C12N 2310/531 (2013.01); C12N 2320/00 (2013.01); C12N 2800/80 (2013.01);
Abstract

Isolation or in vitro assembly of the Cas9-crRNA complex of theCRISPR3/Cas system and use for cleavage of DNA bearing a nucleotide sequence complementary to the crRNA and a proto-spacer adjacent motif. Methods for site-specific modification of a target DNA molecule in vitro or in vivo using an RNA-guided DNA endonuclease comprising RNA sequences and at least one of an RuvC active site motif and an HNH active site motif; for conversion of Cas9 polypeptide into a nickase cleaving one strand of double-stranded DNA by inactivating one of the active sites (RuvC or HNH) in the polypeptide by at least one point mutation; for assembly of active polypeptide-polyribonucleotides complex in vivo or in vitro; and for re-programming a Cas9-crRNA complex specificity in vitro and using a cassette containing a single repeat-spacer-repeat unit.


Find Patent Forward Citations

Loading…